NPS Pharmaceuticals (NPSP)
Create an Alert
14.89
-0.36 -2.36%
NASDAQ
Jun 17, 5:00PM
BATS Real time
Currency in USD
NPS Pharmaceuticals Revenue Quarterly YoY Growth:
10.95% for March 31, 2013NPS Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 10.95% |
| Dec. 31, 2012 | 3.53% |
| Sept. 30, 2012 | 9.83% |
| June 30, 2012 | 96.68% |
| March 31, 2012 | -2.77% |
| Dec. 31, 2011 | 9.21% |
| Sept. 30, 2011 | 16.85% |
| June 30, 2011 | 13.29% |
| March 31, 2011 | 16.15% |
| Dec. 31, 2010 | 9.04% |
| Sept. 30, 2010 | 4.65% |
| June 30, 2010 | -6.36% |
| March 31, 2010 | 24.31% |
| Dec. 31, 2009 | -8.37% |
| Sept. 30, 2009 | -22.84% |
| June 30, 2009 | -4.86% |
| March 31, 2009 | -35.15% |
| Dec. 31, 2008 | -29.18% |
| Sept. 30, 2008 | -10.58% |
| June 30, 2008 | 105.6% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
NPSP Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Alexion Pharmaceuticals | 38.49% |
| Elan | 27350% |
| Vertex Pharmaceuticals | -25.16% |
NPSP Revenue Quarterly YoY Growth Rankings
| Overall |
84th percentile 2584 of 16773 |
| Sector |
78th percentile 304 of 1408 in Healthcare |
| Industry |
79th percentile 95 of 453 in Biotechnology |
NPSP Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -35.15% | Mar 2009 |
| Maximum | 105.6% | Jun 2008 |
| Average | 10.00% |
